These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 24130893)
1. Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein. Yoneda Y; Ito S; Kunisada T; Morimoto Y; Kanzaki H; Yoshida A; Shimizu K; Ozaki T; Ouchida M PLoS One; 2013; 8(10):e77564. PubMed ID: 24130893 [TBL] [Abstract][Full Text] [Related]
2. When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases. Zaborowski M; Vargas AC; Pulvers J; Clarkson A; de Guzman D; Sioson L; Maclean F; Chou A; Gill AJ Histopathology; 2020 Oct; 77(4):588-600. PubMed ID: 32559341 [TBL] [Abstract][Full Text] [Related]
3. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma. Baranov E; McBride MJ; Bellizzi AM; Ligon AH; Fletcher CDM; Kadoch C; Hornick JL Am J Surg Pathol; 2020 Jul; 44(7):922-933. PubMed ID: 32141887 [TBL] [Abstract][Full Text] [Related]
4. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens. Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153 [TBL] [Abstract][Full Text] [Related]
5. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis. Lasota J; Chłopek M; Kaczorowski M; Natálie K; Ryś J; Kopczyński J; Sulaieva O; Michal M; Kruczak A; Harazin-Lechowska A; Szczepaniak M; Koshyk O; Hałoń A; Czapiewski P; Abdullaev Z; Kowalik A; Aldape KD; Michal M; Miettinen M Am J Surg Pathol; 2024 Jan; 48(1):97-105. PubMed ID: 37899499 [TBL] [Abstract][Full Text] [Related]
6. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma. Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114 [TBL] [Abstract][Full Text] [Related]
7. Frequent TRPS1 expression in synovial sarcoma is associated with SS18-SSX fusion oncoprotein activity. Cloutier JM; Ingram DR; Wani K; Lazar AJ; Wang WL Hum Pathol; 2022 Dec; 130():88-94. PubMed ID: 36162599 [TBL] [Abstract][Full Text] [Related]
8. A novel FISH assay for SS18-SSX fusion type in synovial sarcoma. Surace C; Panagopoulos I; Pålsson E; Rocchi M; Mandahl N; Mertens F Lab Invest; 2004 Sep; 84(9):1185-92. PubMed ID: 15208645 [TBL] [Abstract][Full Text] [Related]
9. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. Storlazzi CT; Mertens F; Mandahl N; Gisselsson D; Isaksson M; Gustafson P; Domanski HA; Panagopoulos I Genes Chromosomes Cancer; 2003 Jun; 37(2):195-200. PubMed ID: 12696068 [TBL] [Abstract][Full Text] [Related]
10. Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma. Raquib AR; Hofvander J; Ta M; Nielsen TO Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):531-539. PubMed ID: 35880992 [TBL] [Abstract][Full Text] [Related]
11. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Amary MF; Berisha F; Bernardi Fdel C; Herbert A; James M; Reis-Filho JS; Fisher C; Nicholson AG; Tirabosco R; Diss TC; Flanagan AM Mod Pathol; 2007 Apr; 20(4):482-96. PubMed ID: 17334349 [TBL] [Abstract][Full Text] [Related]
12. The clinical implication of SS18-SSX fusion gene in synovial sarcoma. Ren T; Lu Q; Guo W; Lou Z; Peng X; Jiao G; Sun Y Br J Cancer; 2013 Oct; 109(8):2279-85. PubMed ID: 24022186 [TBL] [Abstract][Full Text] [Related]
13. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation. de Bruijn DR; Allander SV; van Dijk AH; Willemse MP; Thijssen J; van Groningen JJ; Meltzer PS; van Kessel AG Cancer Res; 2006 Oct; 66(19):9474-82. PubMed ID: 17018603 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of SS18-SSX1 expression in synovial sarcoma by small interfering RNA enhances the focal adhesion pathway and inhibits anchorage-independent growth in vitro and tumor growth in vivo. Takenaka S; Naka N; Araki N; Hashimoto N; Ueda T; Yoshioka K; Yoshikawa H; Itoh K Int J Oncol; 2010 Apr; 36(4):823-31. PubMed ID: 20198325 [TBL] [Abstract][Full Text] [Related]
15. Interdependence of SS18-SSX-driven YAP1 and β-Catenin Activation in Synovial Sarcoma. Isfort I; Berthold R; Heinst L; Wardelmann E; Larsson O; Trautmann M; Hartmann W Mol Cancer Res; 2023 Jun; 21(6):535-547. PubMed ID: 36920288 [TBL] [Abstract][Full Text] [Related]
16. The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma. Ishida M; Miyamoto M; Naitoh S; Tatsuda D; Hasegawa T; Nemoto T; Yokozeki H; Nishioka K; Matsukage A; Ohki M; Ohta T Mol Cell Biol; 2007 Feb; 27(4):1348-55. PubMed ID: 17101797 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel SSX1 fusions in synovial sarcoma. Yoshida A; Arai Y; Satomi K; Kubo T; Ryo E; Matsushita Y; Hama N; Sudo K; Komiyama M; Yatabe Y; Shibata T; Ichikawa H; Ichimura K; Kawai A; Mori T Mod Pathol; 2022 Feb; 35(2):228-239. PubMed ID: 34504309 [TBL] [Abstract][Full Text] [Related]